Cardiac resynchronization therapy upregulates cardiac autonomic control.

Area of Science:

• Cardiology
• Autonomic Neuroscience
• Medical Imaging

Background:

• Heart failure (HF) is associated with neurohormonal dysregulation and cardiac autonomic dysfunction, worsening prognosis.
• Mechanical resynchronization via CRT may improve cardiac sympathetic function in HF patients.

Purpose of the Study:

• To evaluate the impact of cardiac resynchronization therapy (CRT) on sympathetic nervous function in patients with heart failure (HF).

Main Methods:

• A prospective study involving 16 HF patients receiving CRT and 10 controls.
• Assessed NYHA class, 6-minute walk distance, echocardiography, and plasma norepinephrine.
• Cardiac sympathetic function evaluated using (123)iodine metaiodobenzylguanidine ((123)I-MIBG) scintigraphy and 24-hour ambulatory ECG.

Main Results:

• CRT improved NYHA class and LVEF, alongside significant increases in the (123)I-MIBG heart/mediastinum ratio and heart rate variability (HRV).
• A significant decrease in (123)I-MIBG washout rate was observed post-CRT.
• Improvements in HF symptoms and LV function correlated with baseline (123)I-MIBG parameters and HRV.

Conclusions:

• Cardiac resynchronization therapy (CRT) leads to improvements in cardiac symptoms and left ventricular (LV) function.
• CRT also promotes rebalanced cardiac autonomic control, as evidenced by (123)I-MIBG scintigraphy and HRV measurements.
• These findings suggest CRT positively impacts sympathetic nervous function in heart failure.